This unit is specialized in delivering the most advanced medical treatment for cancer types patients, providing HCP’s with cutting-edge cancer treatment products (chemotherapy, immunotherapy, targeted therapy, and stem-cell transplant supportive therapy).

Addressing the continuous development of treatment in oncology with the most innovative medicine through our top global specialized pharmaceutical companies including:

  • TAXOTERE® (docetaxel)
  • ZALTRAP® (ziv-aflibercept)
  • LIBTAYO® (cemiplimab-rwlc)
  • MOZOBIL® (plerixafor)
  • JEVTANA® (cabazitaxel)
  • ELOXATIN® (oxaliplatin)
  • FLUDARA® (fludarabine)
  • FASTURTEC® (rasburicase)
  • SARCLISA® (isatuximab)
  • COPIKTRA® (duvelisib)
  • Alimta® (pemetrexed)
  • Cyramza® (ramucirumab)
  • Verzenio (abemaciclib)
  • Zepzelca (lurbinectedin)
  • Cosmegen® (Dactinomycin)
  • LEDAGA (chlormethine gel)
  • Fluta Cell (Flutamide)
  • Oncovin (Vincristine)
  • Bortada (bortezomib)
  • Xaluprine® (Mercaptopurine)
  • Jylamvo (Methotrexate)